When establishing a new cell-based assay, selecting the right cell line is only part of the challenge. Cell culture conditions can have a significant impact on growth, viability, assay consistency, and ultimately the quality of the data generated. For this reason, many researchers are moving towards integrated solutions where cell lines and media have been developed to work together. BPS Bioscience offers a range of engineered cell lines alongside specialised culture media designed for pathway-focused research and immune cell applications, helping researchers spend less time optimising culture conditions and more time generating meaningful results.
Building more reliable cell-based assays
Cell-based models are widely used throughout drug discovery, from target validation and pathway analysis to high-throughput screening and immunotherapy research. However, even a well-characterised cell line can produce inconsistent results if culture conditions are not properly optimised. Media influences multiple aspects of cell performance, including:
- Cell growth and viability
- Expression of target proteins
- Cellular signalling activity
- Functional assay performance
- Experimental reproducibility
Small differences in culture conditions can have a noticeable impact on assay outcomes, making media selection an important consideration when establishing new workflows.
Engineered cell lines designed for demanding applications
BPS Bioscience offers more than 200 engineered cell lines for applications including pathway analysis, drug screening, antibody development and CAR-T research. The portfolio includes reporter cell lines, knockout and overexpression models, co-stimulatory cell lines, and CAR-T reporter systems. These cell lines are extensively validated and tested for viability and mycoplasma contamination prior to shipping. Each product is supplied with detailed protocols to support successful culture and maintenance, helping researchers minimise troubleshooting and accelerate project timelines.
Why use specialised media?
Generic culture media may support cell survival, but specialised formulations can help cells perform more consistently within the context of a specific application.
BPS Bioscience's specialised media has been developed to support pathway-relevant studies and immune cell workflows. When used alongside compatible cell lines, these media can help:
- Optimise culture performance
- Improve experiment-to-experiment consistency
- Support physiologically relevant cellular responses
- Enable efficient immune cell expansion
- Reduce time spent on culture optimisation
For researchers working with complex engineered models, starting with validated combinations of cells and media can simplify assay development and improve confidence in experimental results.
A simpler route to reproducible results
Developing robust cell-based assays often involves balancing biological relevance with reproducibility. Using cell lines and media developed by the same supplier can remove some of the uncertainty associated with establishing culture conditions, particularly when working with specialised reporter systems or immune cell applications.
Rather than optimising multiple variables independently, researchers can begin with products designed to function together, helping to streamline workflow development and support more consistent data generation.
Save 20% when you bundle cells and media
To help researchers access a complete cell culture solution, Cambridge Bioscience is currently offering 20% off for new customers who purchase eligible BPS Bioscience cell lines and specialised media together. The offer is available until 31 December 2026.
For laboratories establishing new assays or expanding existing drug discovery workflows, bundling cells and media provides a convenient way to access validated products designed to work together while reducing overall costs.
Read more related content - Cambridge Bioscience: Life science blog.